Brexpiprazole PurCert Secondary Reference Standard for GC (CRM) [Includes all characterization data]
CRM
Properties
| Assay Purity | >= 99 % |
| M pt. | 179 - 181°C |
| Density | 1.245±0.06 g/cm3 |
| Form | Solid |
Safety Information
| Hazard Statement(s) | H372-H400-H351-H362-H360-H302-H410 |
| Precautionary Statement | P201-P202-P281-P308+P313-P405-P501-P260-P264-P270-P314-P501-P201-P260-P263-P264-P270-P308+P313-P273-P391-P501-P264-P270-P301+P312-P330-P501-P273-P391-P501 |
| GHS Pictogram |
|
| Signal word | Danger |
| HS Code | NA |
| Storage Temp. | 2-8°C |
| Storage Class | NA |
| UN Number | NA |
Description
Application
It is used in the treatment of mental health conditions such as Schizophrenia and as an adjunct therapy for Major Depressive Disorder.
Purpose
The purpose of brexpiprazole is to improve mood thinking and behavior by balancing brain chemicals thereby reducing symptoms like hallucinations depression and anxiety.
General Description
Brexpiprazole is an atypical antipsychotic medication that acts as a partial agonist at serotonin and dopamine receptors helping to modulate neurotransmitter activity in the brain.
Documents
| SDS | |
| COA | |
| Specification | |
| Bulk quote order form | |
| Sample COA |